RMD ResMed Inc
- 31.750
- -0.270-0.84%
ResMed Inc News
AU Evening Wrap: Australian Shares Close Steady as Financials and Real Estate Stocks Rise
Australian shares close steady as financials and real estate stocks rise. Among the 11 sectors of the ASX 200, health is the worst performer, dropping 1.0%.
ResMed Still Showing Value Amid Weight-Loss Drug Trials -- Market Talk
2323 GMT - ResMed's solid growth and balance sheet keep it looking attractive at its current valuation despite the looming specter of further results from weight-loss drug trials, Macquarie analysts s
Insider Sale: CFO Brett Sandercock Sells Shares of ResMed Inc (RMD)
3 ASX 300 Healthcare Stocks 'Well Positioned to Outperform'
The performance of the healthcare sector has been relatively underwhelming in recent times.
Bell Potter Names More of the Best ASX 200 Stocks to Buy in June
If you are hunting some new additions to your portfolio in June, then the ASX 200 stocks listed below could be worth a look.
Are These 2 ASX Healthcare Shares the Best That Money Can Buy?
Two standouts among the crowd are ResMed Inc (ASX: RMD) and CSL Ltd (ASX: CSL). Both companies are leaders in their fields and could offer attractive opportunities for growth and income, in my view.
4 High Quality ASX 200 Growth Shares to Buy in June
Are you wanting to add some ASX 200 growth shares to your portfolio this month?If you are, then it could be well worth checking out the four buy-rated options listed below. Here's what you need to know about these high quality stocks
$20,000 Invested in These ASX 200 Shares 10 Years Ago Is Now Worth... (a Lot!)
I'm a fan of buy and hold investing and believe it is one of the best ways to grow your wealth.
Veeva Systems -11% Q1 Earnings Beat Estimates, Margins Up
ResMed Inc. Publishes Conflict Minerals Report
2 ASX Healthcare Shares to Buy Now for the AI Revolution
If you're looking to capitalise on the artificial intelligence (AI) revolution, you might consider investing in ASX healthcare shares.
4 ASX Growth Shares to Buy to Supercharge Your Portfolio in June
Are you looking to add some growth shares to your investment portfolio in June?If you are, then the four highly rated ASX growth shares listed below could be worth considering.
2 No-brainer ASX 200 Shares to Buy Next Week
There are a lot of quality companies for investors to choose from on the Australian share market.
ResMed Shares Higher as Company 'Turns the GLP Threat Into an Opportunity': Fundie
ResMed CDI (ASX: RMD) shares closed at $32.80 apiece on Tuesday, up 1.14% for the day.
Buy, Hold or Sell These 3 ASX 200 Healthcare Shares: Experts
ASX 200 healthcare shares are in the red with the rest of the market on Friday.
2 of the Best ASX 200 Blue Chip Shares to Buy in May
There are plenty of blue chip shares on the ASX 200 index. But which ones could be buys in May?Let's take a look at two shares that are rated as best buys by a couple of leading brokers right now.
3 Reasons ResMed Shares 'Are Just Too Cheap!'
The Resmed CDI (ASX: RMD) share price has risen 46% over the last six months, and a fund manager reckons there are more gains to come.
AU Evening Wrap: ASX Rally Late to Close Flat; Fletcher Plummets 11%
Consumer and health stocks were the best performers as the benchmark index rallied from almost 0.4% down over the last hour of Monday's session.
Resmed Share Price Higher Despite CEO Hitting Sell on 14,683 Shares
It's been a pleasant Friday for the S&P/ASX 200 Index (ASX: XJO) and most ASX 200 shares today. At the close of trading, the ASX 200 had gained 0.35% and was back above 7,740 points.
Resmed Inc Updates Dividend Exchange Rate
Analysis
Price Target
No Data
